All Type of News
Takeda’s sales policy ignites controversy
Takeda is pushing up with its sales policy to increase its revenues of Basen tablets and Madipine tablets in Korea, but faces vigorous challenges from domestic wholesalers.
With a thinner wholesaler margin, Takeda ...
JW to conduct Phase I trial for new anticancer medicine
JW Pharmaceutical has recently announced that it will conduct Phase I clinical trial for CWP231A, a candidate anticancer medicine that interrupts biochemical signals to eradicate leukemia stem cells without affecting ...
Abbott Korea names new executives
Abbott Korea has recently promoted two directors Kim Bong-ho and Park Chul-min as managing directors for Medical Diagnostics Business Unit.
Kim, 52, entered the company in 1986 after in 1980 after graduating from H...
Listed pharmaceutical companies’ earnings become thinner
The average earnings of 36 firms listed on the main bourse have been aggravating annually due to tough regulations and intense competition at home, Yakup Shinmoon said recently.
The trade paper said that the averag...
OTC sales in clinic will hurt drug store
A scenario raised by a pharmacist said many pharmacies could suffer significant income losses if the government allows over-the-counter drugs at special places including clinics.
The losses are based on an assumpti...
Aloe becomes less popular in Korea
Aloe has become less attractive to Korean people, with other functional foods, such as red ginseng and omega products, getting their momentum.
According to the Korea Food and Drug Administration, the domestic aloe ...
Drug safety monitoring agency to be established
Korea may be able to efficiently cope with drug related adverse reactions (ADRs) within this year.
The National Assembly has recently passed a law revision that would enable the Korea Food and Drug Administration t...
KFDA approves first embryonic stem cell study
A clinical study using embryonic stem cells was approved for the first time in Korea on Wednesday.
The Korea Food and Drug Administration said it has approved CHA Bio & Diostech’s request to conduct a clinical stu...
Finance minister-nominee triggers concerns over OTC sales in non-pharmacy stores
Will Bahk Jae-wan, nominee for health and welfare minister in the recent cabinet reshuffling, push non-pharmacy sales of over the counter (OTC) drugs?
Lee Myung-bak on Friday named one of his closest aides and incu...
EU FTA will hurt pharmaceutical sector
Despite strong protests from opposition parties, the ruling Grand National Party (GNP) Wednesday railroaded a ratification bill of the free trade deal with the European Union.
Of the 169 lawmakers, mostly GNP lawma...
